Literature DB >> 2840871

Mouse hepatitis virus and host determinants of vertical transmission and maternally-derived passive immunity in mice.

S W Barthold1, D S Beck, A L Smith.   

Abstract

Transmission of mouse hepatitis virus (MHV) in utero following oronasal inoculation of pregnant mice was found to depend upon MHV strain and host genotype. Virulent, polytropic MHV-JHM was recovered from multiple maternal tissues, including liver and uterus, as well as placenta and fetus in susceptible BALB/cByJ mice. Fetuses were infected during all 3 trimesters of pregnancy. Low virulence, polytropic MHV-S infected fetuses in a low percentage of susceptible BALB/cByJ dams. Infection of resistant CD-1 mice with MHV-JHM was limited, with no fetal infection. Enterotropic MHV-Y was largely restricted to intestine of BALB/cByJ and CD-1 dams, with minimal dissemination and no fetal infection. Maternally-derived MHV IgG antibody was detectable in pup sera through 4 weeks of age. Antibody titers were generally lower in second litters of the same dam. Cross-fostering experiments showed that antibody was transferred via colostrum and not in utero, and that pups were capable of absorption through 2 weeks of age. Pups nursing immune dams were protected against MHV challenge at 1 and 2 weeks of age, compared to pups nursing naive dams. Immunity to MHV challenge was cross-protective against both antigenically homotypic and heterotypic strains of MHV.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840871      PMCID: PMC7086610          DOI: 10.1007/BF01487681

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  21 in total

1.  Host age and genotypic effects on enterotropic mouse hepatitis virus infection.

Authors:  S W Barthold
Journal:  Lab Anim Sci       Date:  1987-02

2.  Elimination of mouse hepatitis virus from a breeding colony by temporary cessation of breeding.

Authors:  E C Weir; P N Bhatt; S W Barthold; G A Cameron; P A Simack
Journal:  Lab Anim Sci       Date:  1987-08

3.  Transmission of maternal antibodies to Sendai virus in mice and its significance in enzootic infection.

Authors:  T Iida; M Tajima; Y Murata
Journal:  J Gen Virol       Date:  1973-03       Impact factor: 3.891

4.  [Study of the possible effect of prednisolone on placental impermeability to MHV-3 virus in pregnant mice].

Authors:  B Galani; G G Balestrieri; F Piccinino; E Izzo
Journal:  Boll Soc Ital Biol Sper       Date:  1969-03-31

5.  Analysis of age-dependent resistance to murine coronavirus JHM infection in mice.

Authors:  K Pickel; M A Müller; V ter Meulen
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

6.  Epizootic coronaviral typhlocolitis in suckling mice.

Authors:  S W Barthold; A L Smith; P F Lord; P N Bhatt; R O Jacoby; A J Main
Journal:  Lab Anim Sci       Date:  1982-08

7.  New strain of mouse hepatitis virus as the cause of lethal enteritis in infant mice.

Authors:  J C Hierholzer; J R Broderson; F A Murphy
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

8.  Mouse hepatitis virus S in weanling Swiss mice following intranasal inoculation.

Authors:  S W Barthold; A L Smith
Journal:  Lab Anim Sci       Date:  1983-08

9.  Mouse hepatitis virus strain--related patterns of tissue tropism in suckling mice.

Authors:  S W Barthold; A L Smith
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

10.  Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody.

Authors:  S Perlman; R Schelper; E Bolger; D Ries
Journal:  Microb Pathog       Date:  1987-03       Impact factor: 3.738

View more
  14 in total

Review 1.  Overview of new developments in and the future of cryopreservation in the laboratory mouse.

Authors:  Mo Guan; Susan Marschall; Marcello Raspa; Amanda R Pickard; Martin D Fray
Journal:  Mamm Genome       Date:  2012-08-31       Impact factor: 2.957

Review 2.  Pathological involvement of placenta in COVID-19: a systematic review.

Authors:  Rohini Motwani; Vishwajit Deshmukh; Ashutosh Kumar; Chiman Kumari; Khursheed Raza; Hare Krishna
Journal:  Infez Med       Date:  2022-06-01

3.  Passively acquired challenge immunity to enterotropic coronavirus in mice.

Authors:  F R Homberger; S W Barthold
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  Maternally-derived passive immunity to enterotropic mouse hepatitis virus.

Authors:  F R Homberger
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings.

Authors:  Rebecca N Baergen; Debra S Heller
Journal:  Pediatr Dev Pathol       Date:  2020 May-Jun

Review 6.  Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2.

Authors:  Robert W Körner; Mohamed Majjouti; Miguel A Alejandre Alcazar; Esther Mahabir
Journal:  Viruses       Date:  2020-08-12       Impact factor: 5.048

7.  Materno-fetal transmission of human coronaviruses: a prospective pilot study.

Authors:  A Gagneur; E Dirson; S Audebert; S Vallet; M C Legrand-Quillien; Y Laurent; M Collet; J Sizun; E Oger; C Payan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-29       Impact factor: 3.267

Review 8.  SARS-CoV-2: Is it the newest spark in the TORCH?

Authors:  Kathleen M Muldoon; Karen B Fowler; Megan H Pesch; Mark R Schleiss
Journal:  J Clin Virol       Date:  2020-04-14       Impact factor: 3.168

9.  Maternal antibodies protect immunoglobulin deficient neonatal mice from mouse hepatitis virus (MHV)-associated wasting syndrome.

Authors:  E Gustafsson; G Blomqvist; A Bellman; R Holmdahl; A Mattsson; R Mattsson
Journal:  Am J Reprod Immunol       Date:  1996-07       Impact factor: 3.886

10.  Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis.

Authors:  Alexander M Kotlyar; Olga Grechukhina; Alice Chen; Shota Popkhadze; Alyssa Grimshaw; Oded Tal; Hugh S Taylor; Reshef Tal
Journal:  Am J Obstet Gynecol       Date:  2020-07-31       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.